Gene · 572
Papers1,939
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,939
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting PIM kinases in cancer and inflammatory disorders: From mechanisms to clinical translation. | Eur J Med Chem | 2026 | 42822254 | PubTator, text mining | PubMed |
| NaHS inhibits cell proliferation by enhancing oxidative stress and apoptosis in HCT116 cells. | Mol Biol Rep | 2026 | 42455360 | PubTator, text mining | PubMed |
| Network pharmacology of Sijunzi decoction in pancreatic cancer. | Chin Clin Oncol | 2026 | 42425789 | PubTator, text mining | PubMed |
| Targeting BCL-xL in Myeloid Malignancies: From Inhibitors to PROTAC. | J Cell Mol Med | 2026 | 41937490 | PubTator, text mining | PubMed |
| Exploitation of CREB signaling by HTLV-1 and BLV: A central axis in viral persistence and leukemogenesis. | Med Oncol | 2026 | 41774334 | PubTator, text mining | PubMed |
| The Placenta as a Target Organ for Poly- and Perfluoroalkyl Substances (PFASs): Molecular Mechanisms of Toxicity. | Int J Mol Sci | 2026 | 41752174 | PubTator, text mining | PubMed |
| Somatic Mutations in Nuclear and Mitochondrial Genes of Mitochondrial Proteins in Primary and Recurrent Glioblastoma. | Int J Mol Sci | 2026 | 41751913 | PubTator, text mining | PubMed |
| FGF-FGFR Signaling in Parkinson's Disease: Mechanistic Links to Ferroptosis and Neuroprotection. | Brain Sci | 2026 | 41750151 | PubTator, text mining | PubMed |
| Phytochemical and Anti-Ischemic Stroke Properties from the Vitex L. Genus. | Drug Des Devel Ther | 2026 | 41710581 | PubTator, text mining | PubMed |
Fucoxanthin protects placenta-derived human mesenchymal stem cells against oxidative stress-induced apoptosis by modulating genes involved in DNA damage repair, ER stress response, p53-induced apoptosis. | Stem Cell Res Ther | 2025 | 40999517 | PubTator, text mining | PubMed |
| AKT inhibitors in gynecologic oncology: past, present and future. | Front Oncol | 2025 | 40746599 | PubTator, text mining | PubMed |
| The impact of sarcopenia on prognosis and fruquintinib efficacy in advanced colorectal cancer: a retrospective and mendelian randomization study. | Front Immunol | 2025 | 40740773 | PubTator, text mining | PubMed |
| Fucoxanthin inhibits the proliferation of MOLM13 cells by targeting AKT to disrupt glucose metabolism. | Front Pharmacol | 2025 | 40735485 | PubTator, text mining | PubMed |
| Therapeutic Potential of Venetoclax and Selinexor in Targeting Hypoxia-Induced Vulnerabilities in Multiple Myeloma. | Cancer Rep (Hoboken) | 2025 | 40539846 | PubTator, text mining | PubMed |
| Molecular Markers of Occult Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients. | Front Biosci (Landmark Ed) | 2025 | 40018925 | PubTator, text mining | PubMed |
| Editorial: The (un)desirability of cell death in health and disease: emerging modulators and their mechanisms. | Front Cell Dev Biol | 2024 | 39629271 | PubTator, text mining | PubMed |
| Indirubin induces apoptosis in ovarian cancer cells via the mitochondrial pathway. | Am J Transl Res | 2024 | 39544767 | PubTator, text mining | PubMed |
| Digital spatial profiling identifies the tumor center as a topological niche in prostate cancer characterized by an upregulation of BAD. | Sci Rep | 2024 | 39217197 | PubTator, text mining | PubMed |
| Exploring the Cytotoxic and Anticancer Potential of Naringin on Oral Cancer Cell Line. | Cureus | 2024 | 39156270 | PubTator, text mining | PubMed |
| Long non-coding RNA-mediated modulation of endoplasmic reticulum stress under pathological conditions. | J Cell Mol Med | 2024 | 39072992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/572/papers